Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Basset

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Expert Opinion on Drug Safety|February 15, 2021
A safety review of drug treatments for patients with systemic immunoglobulin light chain (AL) amyloidosisMario Nuvolone, Marco Basset, Giovanni Palladini
Expert Review of Hematology|July 30, 2020
Novel challenges in the management of immunoglobulin light chain amyloidosis: from the bench to the bedsideMarco Basset, Mario Nuvolone, Giovanni Palladini, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|September 8, 2017
The lung in amyloidosisPaolo Milani, Marco Basset, Francesca Russo, et al.
Blood|May 27, 2017
Patients with light-chain amyloidosis and low free light-chain burden have distinct clinical features and outcomePaolo Milani, Marco Basset, Francesca Russo, et al.
Blood|January 29, 2017
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosisGiovanni Palladini, Paolo Milani, Andrea Foli, et al.
Blood|November 5, 2017
Presentation and outcome with second-line treatment in AL amyloidosis previously sensitive to nontransplant therapiesGiovanni Palladini, Paolo Milani, Andrea Foli, et al.
Clinical Chemistry and Laboratory Medicine|December 19, 2015
A patient with AL amyloidosis with negative free light chain resultsPaolo Milani, Veronica Valentini, Giovanni Ferraro, et al.
Blood Advances|September 4, 2020
Sequential response-driven bortezomib-based therapy followed by autologous stem cell transplant in AL amyloidosisMarco Basset, Paolo Milani, Mario Nuvolone, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Patterns of relapse after upfront bortezomib therapy in AL amyloidosisMarco Basset, Paolo Milani, Francesca Russo, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Patients with AL amyloidosis and low free light-chain burden have distinct clinical features and outcomePaolo Milani, Marco Basset, Francesca Russo, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Expert Opinion on Drug Safety|February 15, 2021
A safety review of drug treatments for patients with systemic immunoglobulin light chain (AL) amyloidosisMario Nuvolone, Marco Basset, Giovanni Palladini
Expert Review of Hematology|July 30, 2020
Novel challenges in the management of immunoglobulin light chain amyloidosis: from the bench to the bedsideMarco Basset, Mario Nuvolone, Giovanni Palladini, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|September 8, 2017
The lung in amyloidosisPaolo Milani, Marco Basset, Francesca Russo, et al.
Blood|May 27, 2017
Patients with light-chain amyloidosis and low free light-chain burden have distinct clinical features and outcomePaolo Milani, Marco Basset, Francesca Russo, et al.
Blood|January 29, 2017
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosisGiovanni Palladini, Paolo Milani, Andrea Foli, et al.
Blood|November 5, 2017
Presentation and outcome with second-line treatment in AL amyloidosis previously sensitive to nontransplant therapiesGiovanni Palladini, Paolo Milani, Andrea Foli, et al.
Clinical Chemistry and Laboratory Medicine|December 19, 2015
A patient with AL amyloidosis with negative free light chain resultsPaolo Milani, Veronica Valentini, Giovanni Ferraro, et al.
Blood Advances|September 4, 2020
Sequential response-driven bortezomib-based therapy followed by autologous stem cell transplant in AL amyloidosisMarco Basset, Paolo Milani, Mario Nuvolone, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Patterns of relapse after upfront bortezomib therapy in AL amyloidosisMarco Basset, Paolo Milani, Francesca Russo, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Patients with AL amyloidosis and low free light-chain burden have distinct clinical features and outcomePaolo Milani, Marco Basset, Francesca Russo, et al.
Pageof 6